Shuwen Chen

Kunming Medical University

Papers

1

Total Citations

13

H-Index

1

About

Shuwen Chen is a leading researcher in urologic oncology, with a primary focus on advancing surgical techniques for bladder cancer treatment. His work centers on the comparative effectiveness and safety of robot-assisted radical cystectomy (RARC), particularly when combined with intracorporeal urinary diversion (iRARC). Chen’s major contribution lies in providing high-quality evidence through systematic reviews and meta-analyses that critically evaluate whether minimally invasive approaches offer tangible advantages over traditional open surgery. His most cited paper, a 2024 systematic review and meta-analysis, synthesizes data to clarify the differential effects of iRARC on perioperative outcomes, directly addressing a long-standing controversy in the field. With 13 citations, this work has already informed clinical decision-making for surgeons worldwide. Chen’s research is notable for its rigorous methodology and its impact on evidence-based surgical practice, helping to define the evolving role of robotics in complex oncologic procedures. His ongoing investigations continue to shape best practices in urologic surgery, making him a key voice in the transition toward less invasive, yet equally effective, treatment paradigms.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety
13 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Kunming Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago